Breast Cancer

Recruitment For Clinical Study Of Screening Test Begins

Published in Cancer Weekly, June 12th, 2001

Matritech, Inc. (NMPS) announced that it has begun patient recruitment for a multicenter clinical study of its NMP66 blood test for the early detection of breast cancer.

The clinical study, which will be conducted at six medical centers around the U.S., will enroll approximately 1,000 patients. It will include about 700 women with lesions that are either visible on mammogram or palpable, and who have been recommended by their physicians to have a further diagnostic procedure such as biopsy. An additional 300 women with normal mammograms will also be recruited.

The trial will investigate the ability of the NMP66 blood test to detect cancer,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-06-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry